<DOC>
	<DOC>NCT03003104</DOC>
	<brief_summary>The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.</brief_summary>
	<brief_title>DMT210 Topical Gel in the Treatment of Acne Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>Patient is male or nonpregnant female at least 18 years of age. Clinical diagnosis of moderate to severe facial rosacea as determined by Investigator's Global Assessment (IGA) at Randomization Patient has at least ten inflammatory lesions of rosacea on the face at Randomization Patient is willing to apply the Investigational Product as directed Patient is willing and able to comply with the protocol Patient is pregnant or planning to become pregnant Patient is taking a topical therapy which may affect the patient's rosacea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Skin diseases</keyword>
	<keyword>rosacea</keyword>
</DOC>